- Home
- AIDX vs ADXN Comparison
AIDX vs ADXN Comparison
Compare AIDX & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AIDX | ADXN |
|---|---|---|
| Founded | N/A | 2002 |
| Country | United States | Switzerland |
| Employees | 14 | N/A |
| Industry | Precision Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2M | 8.6M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | AIDX | ADXN |
|---|---|---|
| Price | $0.65 | $6.07 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 437.8K | 3.4K |
| Earning Date | N/A | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $86.57 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.54 | $5.41 |
| 52 Week High | $14.09 | $12.05 |
Technical Indicators
Market Signals| Indicator | AIDX | ADXN |
|---|---|---|
| Relative Strength Index (RSI) | 32.60 | 46.72 |
| Support Level | N/A | $5.78 |
| Resistance Level | $1.66 | $7.37 |
| Average True Range (ATR) | 0.12 | 0.35 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 22.78 | 31.91 |
Price Performance
Historical ComparisonAbout AIDX 20/20 Biolabs Inc. Common Stock
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.